Suppr超能文献

Pipemidic acid: absorption, distribution, and excretion.

作者信息

Shimizu M, Nakamura S, Takase Y, Kurobe N

出版信息

Antimicrob Agents Chemother. 1975 Apr;7(4):441-6. doi: 10.1128/AAC.7.4.441.

Abstract

Pipemidic acid was absorbed well by the oral route. Its peak levels in plasma ranged from 4 to 12 mug/ml at an oral dose of about 50 mg/kg in mice, rats, dogs, monkeys, and men. The protein binding of pipemidic acid was about 20% in dog plasma and about 30% in human serum. Pipemidic acid was distributed to most of the organs and tissues tested at the concentrations comparable to or higher than the plasma level. Its concentrations in bile and urine were much higher than the plasma level. About 25 to 88% of orally administered pipemidic acid was excreted into urine in a bacteriologically active form, the percentage depending on the animals and doses employed. The remainder was excreted into feces in men. The main active principle in vivo was unchanged pipemidic acid itself. The mean lethal dose of pipemidic acid after a single oral dose was more than 16,000 mg/kg in mice. No abnormalities were observed in mice orally receiving pipemidic acid once a day for 4 weeks at doses of 1,000, 2,000, and 4,000 mg/kg per day, and in rats orally receiving the drug once a day for 2 weeks at doses of 400 and 1,600 mg/kg per day.

摘要

相似文献

1
Pipemidic acid: absorption, distribution, and excretion.
Antimicrob Agents Chemother. 1975 Apr;7(4):441-6. doi: 10.1128/AAC.7.4.441.
2
Pharmacokinetics of AT-2266 administered orally to mice, rats, dogs, and monkeys.
Antimicrob Agents Chemother. 1983 Jul;24(1):54-60. doi: 10.1128/AAC.24.1.54.
4
Pharmacokinetic studies of norfloxacin in laboratory animals.
Chemotherapy. 1984;30(5):288-96. doi: 10.1159/000238283.
7
Pipemidic acid: its activities against various experimental infections.
Antimicrob Agents Chemother. 1976 Apr;9(4):569-74. doi: 10.1128/AAC.9.4.569.

引用本文的文献

1
Recent Development of Fluoroquinolone Derivatives as Anticancer Agents.
Molecules. 2024 Jul 27;29(15):3538. doi: 10.3390/molecules29153538.
3
Comparative pharmacokinetic profiles of cinoxacin and pipemidic acid in humans.
Eur J Drug Metab Pharmacokinet. 1983 Jul-Sep;8(3):251-9. doi: 10.1007/BF03188755.
4
Single- and multiple-dose pharmacokinetics of pipemidic acid in normal human volunteers.
Antimicrob Agents Chemother. 1984 Jul;26(1):69-73. doi: 10.1128/AAC.26.1.69.
5
Selective decontamination of the digestive tract by pipemidic acid.
Antimicrob Agents Chemother. 1983 Dec;24(6):902-4. doi: 10.1128/AAC.24.6.902.
6
In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound.
Antimicrob Agents Chemother. 1983 May;23(5):658-63. doi: 10.1128/AAC.23.5.658.
7
In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid.
Eur J Clin Microbiol. 1983 Apr;2(2):111-5. doi: 10.1007/BF02001575.
8
Determination of pipemidic acid in plasma by normal-phase high-pressure liquid chromatography.
Antimicrob Agents Chemother. 1985 Aug;28(2):192-4. doi: 10.1128/AAC.28.2.192.
10
Pipemidic acid: its activities against various experimental infections.
Antimicrob Agents Chemother. 1976 Apr;9(4):569-74. doi: 10.1128/AAC.9.4.569.

本文引用的文献

1
ABSORPTION, EXCRETION, AND METABOLISM OF A NEW ANTIBACTERIAL AGENT, NALIDIXIC ACID.
Toxicol Appl Pharmacol. 1964 May;6:292-309. doi: 10.1016/0041-008x(64)90070-5.
3
Oxolinic acid metabolism by man.
Arch Int Pharmacodyn Ther. 1968 Aug;174(2):413-27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验